Literature DB >> 19428491

Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Jonathan Savitz1, Wayne C Drevets.   

Abstract

Both major depressive disorder and bipolar disorder are the subject of a voluminous imaging and genetics literature. Here, we attempt a comprehensive review of MRI and metabolic PET studies conducted to date on these two disorders, and interpret our findings from the perspective of developmental and degenerative models of illness. Elevated activity and volume loss of the hippocampus, orbital and ventral prefrontal cortex are recurrent themes in the literature. In contrast, dorsal aspects of the PFC tend to display hypometabolism. Ventriculomegaly and white matter hyperintensities are intimately associated with depression in elderly populations and likely have a vascular origin. Important confounding influences are medication, phenotypic and genetic heterogeneity, and technological limitations. We suggest that environmental stress and genetic risk variants interact with each other in a complex manner to alter neural circuitry and precipitate illness. Imaging genetic approaches hold out promise for advancing our understanding of affective illness.

Entities:  

Mesh:

Year:  2009        PMID: 19428491      PMCID: PMC2858318          DOI: 10.1016/j.neubiorev.2009.01.004

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  591 in total

1.  Quantitative MRI of the hippocampus and amygdala in severe depression.

Authors:  E Mervaala; J Föhr; M Könönen; M Valkonen-Korhonen; P Vainio; K Partanen; J Partanen; J Tiihonen; H Viinamäki; A K Karjalainen; J Lehtonen
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

2.  Frontal white matter anisotropy and symptom severity of late-life depression: a magnetic resonance diffusion tensor imaging study.

Authors:  K Nobuhara; G Okugawa; T Sugimoto; T Minami; C Tamagaki; K Takase; Y Saito; S Sawada; T Kinoshita
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

3.  Subjective memory complaints, white-matter lesions, depressive symptoms, and cognition in elderly patients.

Authors:  Thaís S C Minett; Jennie L Dean; Michael Firbank; Philip English; John T O'Brien
Journal:  Am J Geriatr Psychiatry       Date:  2005-08       Impact factor: 4.105

4.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.

Authors:  M H Chakos; J A Lieberman; J Alvir; R Bilder; M Ashtari
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

5.  Body mass index and white matter lesions in elderly women. An 18-year longitudinal study.

Authors:  D R Gustafson; B Steen; I Skoog
Journal:  Int Psychogeriatr       Date:  2004-09       Impact factor: 3.878

6.  A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.

Authors:  Sean P David; Naga Venkatesha Murthy; Eugenii A Rabiner; Marcus R Munafó; Elaine C Johnstone; Robyn Jacob; Robert T Walton; Paul M Grasby
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

7.  White matter abnormalities in children with and at risk for bipolar disorder.

Authors:  Jean A Frazier; Janis L Breeze; George Papadimitriou; David N Kennedy; Steven M Hodge; Constance M Moore; James D Howard; Michael P Rohan; Verne S Caviness; Nikos Makris
Journal:  Bipolar Disord       Date:  2007-12       Impact factor: 6.744

8.  Tianeptine attenuates stress-induced morphological changes in the hippocampus.

Authors:  Y Watanabe; E Gould; D C Daniels; H Cameron; B S McEwen
Journal:  Eur J Pharmacol       Date:  1992-11-03       Impact factor: 4.432

9.  Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry.

Authors:  Richard A Lochhead; Ramin V Parsey; Maria A Oquendo; J John Mann
Journal:  Biol Psychiatry       Date:  2004-06-15       Impact factor: 13.382

10.  Decreased expression of Sprouty2 in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder: a correlation with BDNF expression.

Authors:  Anilkumar Pillai
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

View more
  157 in total

1.  Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study.

Authors:  Jonathan B Savitz; Allison C Nugent; Wendy Bogers; Jonathan P Roiser; Earle E Bain; Alexander Neumeister; Carlos A Zarate; Husseini K Manji; Dara M Cannon; Sean Marrett; Fritz Henn; Dennis S Charney; Wayne C Drevets
Journal:  Biol Psychiatry       Date:  2010-11-20       Impact factor: 13.382

2.  Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.

Authors:  Rong-Jian Liu; Francis S Lee; Xiao-Yuan Li; Francis Bambico; Ronald S Duman; George K Aghajanian
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

3.  A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders.

Authors:  Hans-Gert Bernstein; Melanie Klix; Henrik Dobrowolny; Ralf Brisch; Johann Steiner; Hendrik Bielau; Tomasz Gos; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-02-17       Impact factor: 5.270

Review 4.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

5.  Translating progress in depression research to the clinic: one step at a time on a very long road.

Authors:  Wayne C Drevets
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

6.  Stuck in a rut: rethinking depression and its treatment.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  Trends Neurosci       Date:  2010-11-08       Impact factor: 13.837

7.  Abnormal temporal lobe white matter as a biomarker for genetic risk of bipolar disorder.

Authors:  Katie Mahon; Katherine E Burdick; Toshikazu Ikuta; Raphael J Braga; Patricia Gruner; Anil K Malhotra; Philip R Szeszko
Journal:  Biol Psychiatry       Date:  2012-10-01       Impact factor: 13.382

Review 8.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

9.  Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.

Authors:  Jonathan Savitz; Robert Dantzer; Brent E Wurfel; Teresa A Victor; Bart N Ford; Jerzy Bodurka; P S F Bellgowan; T Kent Teague; Wayne C Drevets
Journal:  Psychoneuroendocrinology       Date:  2014-11-24       Impact factor: 4.905

10.  Basal ganglia morphology links the metabolic syndrome and depressive symptoms.

Authors:  Ikechukwu C Onyewuenyi; Matthew F Muldoon; Israel C Christie; Kirk I Erickson; Peter J Gianaros
Journal:  Physiol Behav       Date:  2013-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.